Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|April 11, 2024
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern SpainLaura Basterretxea Badiola, Nuria Lainez Milagro, Diego Cacho Lavín, et al.
Pharmacogenomics|March 30, 2016
SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinomaIgnacio Duran, Carlos Hagen, José Ángel Arranz, et al.
European Urology Focus|June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract CarcinomaCora N Sternberg, Yohann Loriot, Ernest Choy, et al.
The New England Journal of Medicine|March 6, 2024
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial CancerThomas Powles, Begoña P Valderrama, Shilpa Gupta, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Nature Medicine|November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
BJC Reports|November 8, 2024
Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational studyChantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, et al.
International Journal of Cancer|May 16, 2018
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancerBeatriz Paumard-Hernández, Oriol Calvete, Lucia Inglada Pérez, et al.
Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.
The Lancet. Oncology|September 24, 2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trialThomas Powles, Michiel S van der Heijden, Daniel Castellano, et al.
Pageof 9